Literature DB >> 9570788

Granule neuron regulation of Purkinje cell development: striking a balance between neurotrophin and glutamate signaling.

M E Morrison1, C A Mason.   

Abstract

Granule neurons, presynaptic afferents of Purkinje cells, are potent regulators of Purkinje cell development. Purified Purkinje cells survive and differentiate poorly, whereas coculture with granule neurons enhances their survival and dendritic development. Here we investigate the role of neurotrophins in granule-Purkinje cell interactions. BDNF or NT-4 improves, but NT-3 or CNTF reduces, survival of isolated Purkinje cells. When granule neurons are present, however, BDNF or NT-4 treatment leads to Purkinje cell loss. This decrease is overcome by anti-BDNF or TrkB-IgG-blocking reagents or by CNQX, a non-NMDA glutamate receptor antagonist. Furthermore, BDNF increases the spine density on the surviving Purkinje cells. These results suggest that Purkinje cell survival and differentiation are context-dependent and require a balance between neurotrophin- and activity-dependent signaling.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570788      PMCID: PMC6793141     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  74 in total

1.  Osteogenic protein-1 induces dendritic growth in rat sympathetic neurons.

Authors:  P Lein; M Johnson; X Guo; D Rueger; D Higgins
Journal:  Neuron       Date:  1995-09       Impact factor: 17.173

Review 2.  Neurotrophins and cerebellar development.

Authors:  D Lindholm; S Hamnér; U Zirrgiebel
Journal:  Perspect Dev Neurobiol       Date:  1997

3.  The cellular patterns of BDNF and trkB expression suggest multiple roles for BDNF during Xenopus visual system development.

Authors:  S Cohen-Cory; E Escandón; S E Fraser
Journal:  Dev Biol       Date:  1996-10-10       Impact factor: 3.582

4.  Kainic acid-induced excitotoxicity is associated with a complex c-Fos and c-Jun response which does not preclude either cell death or survival.

Authors:  E Pozas; J Ballabriga; A M Planas; I Ferrer
Journal:  J Neurobiol       Date:  1997-09

5.  Basic fibroblast growth factor protects cerebellar neurons in primary culture from NMDA and non-NMDA receptor mediated neurotoxicity.

Authors:  M T Fernández-Sánchez; A Novelli
Journal:  FEBS Lett       Date:  1993-11-29       Impact factor: 4.124

6.  Effects of brain-derived neurotrophic factor on optic axon branching and remodelling in vivo.

Authors:  S Cohen-Cory; S E Fraser
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

7.  Immunohistochemical visualization of brain-derived neurotrophic factor in the rat brain.

Authors:  M M Dugich-Djordjevic; C Peterson; F Isono; F Ohsawa; H R Widmer; T L Denton; G L Bennett; F Hefti
Journal:  Eur J Neurosci       Date:  1995-09-01       Impact factor: 3.386

8.  Inhibition of ocular dominance column formation by infusion of NT-4/5 or BDNF.

Authors:  R J Cabelli; A Hohn; C J Shatz
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

9.  Brain-derived neurotrophic factor is a survival factor for cultured rat cerebellar granule neurons and protects them against glutamate-induced neurotoxicity.

Authors:  D Lindholm; G Dechant; C P Heisenberg; H Thoenen
Journal:  Eur J Neurosci       Date:  1993-11-01       Impact factor: 3.386

10.  Neuronal regulation of astroglial morphology and proliferation in vitro.

Authors:  M E Hatten
Journal:  J Cell Biol       Date:  1985-02       Impact factor: 10.539

View more
  42 in total

1.  Activity-dependent activation of TrkB neurotrophin receptors in the adult CNS.

Authors:  R Aloyz; J P Fawcett; D R Kaplan; R A Murphy; F D Miller
Journal:  Learn Mem       Date:  1999 May-Jun       Impact factor: 2.460

2.  Ultrastructural localization of full-length trkB immunoreactivity in rat hippocampus suggests multiple roles in modulating activity-dependent synaptic plasticity.

Authors:  C T Drake; T A Milner; S L Patterson
Journal:  J Neurosci       Date:  1999-09-15       Impact factor: 6.167

3.  Afferent-target cell interactions in the cerebellum: negative effect of granule cells on Purkinje cell development in lurcher mice.

Authors:  M L Doughty; A Lohof; F Selimi; N Delhaye-Bouchaud; J Mariani
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

4.  The regulatory connection between the activity of granule cell NMDA receptors and dendritic differentiation of cerebellar Purkinje cells.

Authors:  H Hirai; T Launey
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

5.  Inhibition of protein kinase C prevents Purkinje cell death but does not affect axonal regeneration.

Authors:  Abdel M Ghoumari; Rosine Wehrlé; Chris I De Zeeuw; Constantino Sotelo; Isabelle Dusart
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

Review 6.  Neurotrophic effects of AMPA.

Authors:  Cristina Limatola
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

7.  Dendrites contain a spacing pattern.

Authors:  Aaron B Taylor; Justin R Fallon
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

8.  The actions of BDNF on dendritic spine density and morphology in organotypic slice cultures depend on the presence of serum in culture media.

Authors:  Christopher A Chapleau; Maria E Carlo; Jennifer L Larimore; Lucas Pozzo-Miller
Journal:  J Neurosci Methods       Date:  2007-12-23       Impact factor: 2.390

9.  BDNF-mediated cerebellar granule cell development is impaired in mice null for CaMKK2 or CaMKIV.

Authors:  Manabu Kokubo; Masahiro Nishio; Thomas J Ribar; Kristin A Anderson; Anne E West; Anthony R Means
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

10.  Distinct modes of neuritic growth in purkinje neurons at different developmental stages: axonal morphogenesis and cellular regulatory mechanisms.

Authors:  Annarita de Luca; Stefania Vassallo; Beatriz Benitez-Temino; Gianluca Menichetti; Ferdinando Rossi; Annalisa Buffo
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.